Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 14;9(2):242.
doi: 10.1038/s41419-018-0271-0.

The cytotoxicity of coxsackievirus B3 is associated with a blockage of autophagic flux mediated by reduced syntaxin 17 expression

Affiliations

The cytotoxicity of coxsackievirus B3 is associated with a blockage of autophagic flux mediated by reduced syntaxin 17 expression

Lang Tian et al. Cell Death Dis. .

Abstract

Coxsackievirus B3 (CVB3) is an important human pathogen linked to cardiac arrhythmias and acute heart failure. CVB3 infection has been reported to induce the formation of autophagosomes that support the viral replication in host cells. Interestingly, our study shows that the accumulation of autophagosomes during CVB3 infection is caused by a blockage of autophagosome-lysosome fusion rather than the induction of autophagosome biogenesis. Moreover, CVB3 decreases the transcription and translation of syntaxin 17 (STX17), a SNARE (soluble N-ethylmaleimide-sensitive factor activating protein receptor) protein involved in autophagosome-lysosome fusion. Overexpression of STX17 restored the autophagic flux, alleviated the virus-induced lysosomal dysfunction, and decreased the apoptosis induced by CVB3 infection in HeLa cells. Taken together, our results suggest that CVB3 infection impairs the autophagic flux by blocking autophagosome-lysosome fusion. These findings thus point to potential new therapeutic strategies targeting STX17 or autophagosome-lysosome fusion for treating CVB3-associated diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. CVB3 induces LC3-II accumulation in dose-dependent manner.
a HeLa cells were infected with CVB3 at a low (CVB3-L) and high MOI (CVB-H) and incubated for 36 h. Endogenous LC3B was detected by immunofluorescence. b Western blotting was employed to detect LC3B; VP1: a CVB3 viral protein; p62: a substrate for autophagic degradation; actin: a loading control. c Statistical analysis for a vs. Control, **p < 0.01. d Statistical analysis of the ratio of LC3B-II to LC3B-I, normalized to actin for b vs. Control, **p < 0.01. d Western blotting was employed to detect Triton X-100-soluble and Triton X-insoluble ubiquitin-conjugated proteins after infection with CVB3 at low (CVB3-L) and high MOI (CVB-H), respectively, and incubation for 36 h. Actin is a loading control. e Statistical analysis of the ratio of insoluble ubiquitin conjugates to actin, normalized to actin for d. *p < 0.05, **p < 0.01
Fig. 2
Fig. 2. Baf1 blocks accumulation of LC3-II induced by CVB3 infection.
a HeLa cells were infected with CVB3 at a high MOI and treated with 50 nM Baf1 for 12 h. Endogenous LC3B was detected by western blotting. VP1: a CVB3 viral protein. Actin: a loading control. b Statistical analysis of the ratio of LC3B-II to LC3B-I, normalized to actin vs. Control. *p < 0.01. NS, no statistical significance
Fig. 3
Fig. 3. CVB3 infection increases autophagic vesicles by blockage of autophagosome–lysosome fusion.
a The monomeric red fluorescent protein (mRFP)-GFP-LC3 tandem reporter was used to transfect HeLa cells with or without CVB3 infection. If autophagic flux is increased, the number of both yellow and red puncta are increased; if autophagosome maturation into autolysosomes is blocked, only the number of yellow puncta is increased, without a concomitant increase of the number of red puncta. b After 24 h of transfection, yellow puncta were counted. Quantification of the percentage of yellow dots (GFP+/RFP+ dots), which contain both GFP and mRFP signal (autophagosomes), out of the total number of red dots (RFP+ dots) vs. Control. **p < 0.01. c A representative ultrastructural picture of CVB3-infected HeLa cells. Autophagosome-like vacuoles are indicated by arrows. Scale bar = 1 µm
Fig. 4
Fig. 4. CVB3 infection inhibits transcription of STX17.
a Endogenous STX17 was detected in CVB3-infected HeLa cells by western blotting. VP1: a CVB3 viral protein. Actin: a loading control. b Statistical analysis for a vs. Control. **p < 0.01. c Transcription of STX17 and Lamp1 was measured in CVB3- infected HeLa cells by real-time PCR vs. Control. **p < 0.01
Fig. 5
Fig. 5. Exogenous STX17 restores impaired autophagosome–lysosome fusion following CVB3 infection.
a CVB3-infected HeLa cells were transfected with STX17-myc or empty vector. LC3 was detected in CVB3-infected HeLa cells by western blotting. VP1: a CVB3 viral protein. Actin: a loading control. b Statistical analysis for a vs. CVB3. *p < 0.05. c The monomeric red fluorescent protein (mRFP)-GFP-LC3 tandem reporter and STX17-myc were used to transfect HeLa cells with CVB3 infection. d Yellow puncta were counted. Quantification of the percentage of yellow dots (GFP+/RFP+ dots), which contain both GFP and mRFP signal (autophagosomes), out of the total number of red dots (RFP+ dots). vs. CVB3. *p < 0.05. e Ultrastructural analysis of CVB3-infected HeLa cells transfected with STX17-myc or sham. Autophagosome-like vacuoles are indicated by arrows. Scale bar = 1 µm
Fig. 6
Fig. 6. STX17 restored lysosomal function and blocked apoptosis induced by CVB3 infection.
a Western blotting was employed to detect Triton X-100-insoluble ubiquitin-conjugated proteins in cells with or without exogenous expression of STX17 after infection with CVB3. b Statistical analysis of the ratio of insoluble ubiquitin conjugates to actin, normalized to actin for a, *p < 0.05, **p < 0.01. c The activity of cathepsin B/L was measured in cells with or without exogenous expression of STX17 after infection with CVB3, *p < 0.05. d Annexin V + PI staining for the flow-cytometric measurement of apoptosis induced by CVB3 infection. e Cleaved caspase-3 was detected in CVB3-infected HeLa cells transfected with STX17-myc or sham. f Statistical analysis for a vs. CVB3. *p < 0.01

References

    1. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad. Med. J. 2001;77:4–10. doi: 10.1136/pmj.77.903.4. - DOI - PMC - PubMed
    1. Kadambari S, et al. Enterovirus infections in England and Wales, 2000–2011: the impact of increased molecular diagnostics. Clin. Microbiol. Infect. 2014;20:1289–96. doi: 10.1111/1469-0691.12753. - DOI - PubMed
    1. Lee CJ, et al. Clinical features of coxsackievirus A4, B3 and B4 infections in children. PLoS ONE. 2014;9:e87391. doi: 10.1371/journal.pone.0087391. - DOI - PMC - PubMed
    1. Khetsuriani N, Lamonte A, Oberste MS, Pallansch M. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983–2003. Pediatr. Infect. Dis. J. 2006;25:889–93. doi: 10.1097/01.inf.0000237798.07462.32. - DOI - PubMed
    1. Huber S, Ramsingh AI. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004;17:358–69. doi: 10.1089/vim.2004.17.358. - DOI - PubMed

Publication types

MeSH terms